Leave the first review for product
Product:
EH_ESD_LucenceInsight_50Evangel Hospital LucenceINSIGHT™ Multi-Cancer Early Screening 50 (Include 50 Cancer Types)
51items
Recommended for
- Aged 40+
- Have family history of cancer
- Have diet or lifestyle risk factors
- NOT recommended for patients who: are pregnant, are in cancer remission for less than 3 years, had surgery, an allogenic bone transplant or a blood transfusion less than 2 weeks prior to sample collection
HK$23,380.0
Earn 70,140 Points (HK$701)
Choose the same timeslot to enjoy offer!
Compare
WishList
Doctor Consultation
Highlight-
Doctor's Consultation (Twice)
LucenceINSIGHT Multi-Cancer Early Screening
-
Thyroid Cancer
-
Breast Cancer
-
Liver Cancer
-
Lung Cancer
-
Pancreatic Cancer
-
Colorectal Cancer
-
Nasopharyngeal Cancer (EBV+)
-
Esophageal Cancer
-
Stomach Cancer
-
Kidney Cancer (Clear Cell)
-
Gastrointestinal Stromal Tumor (GIST)
-
Bladder Cancer
-
Prostate Cancer (Male Only)
-
Ovarian Cancer (Female Only)
-
Cervical Cancer (Female Only)
-
Endometrial Cancer (Female Only)
-
Eye Cancer (Conjunctival Melanoma)
-
Eye Cancer (Uveal Melanoma)
-
Oropharyngeal Cancer (HPV-Negative)
-
Oropharyngeal Cancer (HPV-Positive)
-
Laryngeal Cancer
-
Salivary Gland Cancer
-
Lung Neuroendocrine Tumor
-
Stomach Neuroendocrine Tumor
-
Biliary Tract Cancer (Intrahepatic)
-
Biliary Tract Cancer (Extrahepatic)
-
Biliary Tract Cancer (Gall Bladder)
-
Small Intestine Cancer
-
Colorectal Neuroendocrine Tumor
-
Ovarian Germ Cell & Stromal Tumour (Female Only)
-
Vulvar Cancer (Female Only)
-
Non-Hodgkin Lymphoma (Burkitt's Lymphoma)
-
Non-Hodgkin Lymphoma (Diffuse Large B-Cell Lymphoma)
-
Non-Hodgkin Lymphoma (Lymphoplasmacytic Lymphoma)
-
Hairy Cell Leukemia
-
Acute Myeloid Leukemia (Myelodysplasia-related)
-
Acute Myeloid Leukemia (NPM1 Mutation)
-
Acute Myeloid Leukemia (Other Defined Genetic Alterations)
-
Myeloproliferative Neoplasm
-
Mast Cell Tumor
-
Myeloma
-
Bone Cancer
-
Soft Tissue (Angiosarcoma)
-
Soft Tissue (Smooth Muscle Sarcoma)
-
Adrenal Gland Cancer
-
Adult Wilms Tumor
-
Penile Cancer (Male Only)
-
Testicular Cancer (Male Only)
-
Skin Cancer (Melanoma)
-
Skin Cancer (Non-Melanoma)
LucenceINSIGHT™ is a multi-cancer early detection (MCED) next-generation sequencing blood test. This test can provide a comprehensive screening for 50 types of cancers.
The test is recommended for individuals with elevated risk of cancer, such as those who:
• Aged 40+
• Have family history of cancer
• Have diet or lifestyle risk factors
No fasting is needed. Patients should maintain a light diet for 4 hours prior to the test; patients undergoing hemodialysis must have their blood drawn before dialysis.
LucenceINSIGHT™ is a multi-cancer early detection (MCED) next-generation sequencing blood test. The test uses Lucence's technology to detect and analyze circulating tumor DNA (ctDNA), circulating tumor RNA (ctRNA) and cancer-associated viral DNA. It then identifies potential tumor location (s) with machine learning. The advantages of the test are as follows:
• 99% Specificity (helps reduce false positives)
• 81% Sensitivity
• 88% Accuracy in tumor localization
• 100% Positive Predictive Value
(Figures provided by LucenceINSIGHT)
This test can screen for 50 cancer types, including:
Lung cancer, Lung Neuroendocrine Tumour, Breast Cancer, Nasopharyngeal Cancer (EBV+), Laryngeal Cancer, Oropharyngeal Cancer (HPV-Positive), Oropharyngeal Cancer (HPV-Negative), Salivary Gland Cancer, Adrenal Gland Cancer, Adult Wilms Tumour,Bladder Cancer, Kidney Cancer (Clear Cell), Pancreatic Cancer, Biliary Tract Cancer (Intrahepatic), Biliary Tract Cancer (Extrahepatic), Biliary Tract Cancer (Gall Bladder), Liver Cancer, Colorectal Cancer, Colorectal Neuroendocrine Tumour, Gastrointestinal Stromal Tumor (GIST), Stomach Cancer, Stomach Neuroendocrine Tumor, Esophageal Cancer, Small Intestine Cancer, Acute Myeloid Leukemia(Myelodysplasia-related), Acute Myeloid Leukemia(NPM1 Mutation), Acute Myeloid Leukemia(Other Defined Genetic Alterations), Mast Cell Tumour, Myeloproliferative Neoplasm, Myeloma, Non-Hodgkin Lymphoma(Burkitt’s Lymphoma), Non-Hodgkin Lymphoma(Diffuse Large B-Cell Lymphoma), Non-Hodgkin Lymphoma(Lymphoplasmacytic Lymphoma), Hairy Cell Leukemia, Eye Cancer (Conjunctival Melanoma), Eye Cancer (Uveal Melanoma), Skin Cancer (Melanoma), Skin Cancer (Non-Melanoma), Thyroid Cancer, Bone Cancer, Soft Tissue (Angiosarcoma), Soft Tissue (Smooth Muscle Sarcoma).
• For Men Only:
Prostate Cancer, Penile Cancer, Testicular Cancer.
• For Women only:
Cervical Cancer, Endometrial Cancer, Ovarian Cancaer, Vulvar Cancer, Ovarian Germ Cell & Stromal Tumour.
The above price has included the report analysis and two doctor consultations before and after the screening.
Terms and Conditions:
•These cancer screenings are preliminary tests only. If a patient’s sample tests positive for cancer cell genes, the patient may consider further examinations and treatment based on the doctor’s advice.
•This offer cannot be combined with other promotions.
•The Hospital reserves the final right to provide services and interpret the terms.
• This test does not assess inherited cancer risk and no genetic counseling is needed.
• This test is not a diagnostic test and positive results require follow-up testing.
• This test should complement but not replace routine screenings.
• This test detects only listed cancers and other cancers may still occur.
• Brain tumors are not included in the test due to limited ctDNA + ctRNA release into circulation.
• False positives and false negatives can occur and annual testing is recommended.
Payment and Confirmation of Purchased Health Check Items
After the customer receives the confirmation email of successful payment sent by health.ESDlife, a related email will also be sent to the designated email address of the Evangel Hospital (The Hospital). The physical checkup or medical services purchased by the customer have been successfully booked. Unless Evangel Hospital has additional information to notify the customer, the customer only needs to visit the hospital on the specified date and time for the scheduled check-up or service.
Age
The health check program or medical services are only applicable to individuals aged 18 and above. (Except for some special plans)
Validity
The purchased service is valid for 3 months starting from the date of payment. Clients must undergo the relevant procedure within the validity period and must make an appointment at least one month before the expiration of the validity period. Any appointments made after this period will be void, and no refunds will be issued.
Collection of Checkup Reports
The Hospital's physical checkup service includes the doctor's assessment fees before and after the service. Generally, the Hospital will schedule an appointment for the customer to return to collect the report around 14 working days (excluding Saturdays, Sundays, and public holidays).
Note The waiting time for report explanation may vary depending on different circumstances (such as the time required for specific test items or if the customer specifies a particular time). If the doctor finds any abnormalities in the test reports, the customer will be notified as soon as possible for immediate follow-up.
Collection Method
Customers must visit the hospital in person to collect the report, which our doctor will explain the report in details.
Terms and Conditions
1. Customers must collect their medical examination report within eight weeks after the check-up; otherwise, they will be required to pay an additional doctor’s consultation fee (Mon - Sat: $285; Sun & Public Holidays: $395).
2. Customers should arrive at the hospital at least 10 minutes before the scheduled appointment time. If customers arrive over an hour late, miss the appointment, or do not attend, the hospital will not provide rescheduling or refund arrangements.
3. If customers require additional copies of the report, the hospital will charge an administrative fee.
Inquiries
If customers have any other inquiries, please call 2760 3442 / Whatsapp 57414933 to contact the outpatient department staff of the hospital.
